NCT02174367View on ClinicalTrials.gov

An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2021

Conditions
Psoriasis ChronicLiver FibrosisFatty LiverNon-alcoholic Fatty Liver Disease
Interventions
DEVICE

Transient elastography

a noninvasive tool for measuring liver stiffness as a predictor of liver fibrosis

Trial Locations (1)

SE1 9RT

Guys and St Thomas NHS Foundation trust and King's College London, London

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

King's College London

OTHER

NCT02174367 - An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis | Biotech Hunter | Biotech Hunter